Literature DB >> 11322483

F508 amino acid deletion mutation of CFTR gene in Korean lung cancer patients.

Y Jung1, H Ha, S H Jung, M G Lee, H W Lee, J Yoon, J W Choi, B I Yeh.   

Abstract

Mutations of the transmembrane conductance regulator (CFTR) gene in cystic fibrosis lead to dysfunction of the lung, pancreas, and sweat glands, etc. To investigate the possibility of the relationship between lung cancer and the mutations of CFTR gene, we determined amino acid sequences using reverse transcription-polymerase chain reaction (RT-PCR) and DNA sequencing. In this study, the deletion mutation of 508th amino acid in one of nine lung caner patients was found confirming that CFTR gene mutation exists in a Korean lung cancer patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322483     DOI: 10.1038/emm.2001.6

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  4 in total

Review 1.  Emerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancers.

Authors:  Yuning Hou; Xiaoqing Guan; Zhe Yang; Chunying Li
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

2.  Report of a Korean patient with cystic fibrosis, carrying Q98R and Q220X mutations in the CFTR gene.

Authors:  Won-Jung Koh; Chang-Seok Ki; Jong-Won Kim; Jeong-Ho Kim; Seong Yong Lim
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

Review 3.  Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer.

Authors:  Jieting Zhang; Yan Wang; Xiaohua Jiang; Hsiao Chang Chan
Journal:  Cell Mol Life Sci       Date:  2018-02-06       Impact factor: 9.261

4.  MicroRNA global profiling in cystic fibrosis cell lines reveals dysregulated pathways related with inflammation, cancer, growth, glucose and lipid metabolism, and fertility: an exploratory study.

Authors:  Cecilia Catellani; Francesca Cirillo; Sara Graziano; Luisa Montanini; Nelson Marmiroli; Mariolina Gullì; Maria Elisabeth Street
Journal:  Acta Biomed       Date:  2022-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.